Insulet Corp.
PODD
株式のランク
#2096
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
株価
$142.09
時価総額
$9.85B
変化（1日）
-0.39%
変化（1年）
-56.81%
国
US
取引 Insulet Corp. (PODD)
カテゴリー
Healthcare
Insulet Corp.（PODD）の株価履歴
終値の最高値: $137.02 （2026-10-01）
終値の最安値: $15.32 （2007-05-01）
終値の最安値: $15.32 （2007-05-01）
Insulet Corp. の株価履歴（2007 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | -28.61% |
| 2025 | 10.94% |
| 2024 | 29.28% |
| 2023 | -31.55% |
| 2022 | 12.13% |
| 2021 | 7.15% |
| 2020 | 41.98% |
| 2019 | 122.73% |
| 2018 | 14.06% |
| 2017 | 87.47% |
| 2016 | -0.45% |
| 2015 | -18.45% |
| 2014 | 23.64% |
| 2013 | 70.93% |
| 2012 | 17.30% |
| 2011 | 23.42% |
| 2010 | 14.55% |
| 2009 | 83.92% |
| 2008 | -70.52% |
| 2007 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $100.56 | -21.15% |
US
|
|
| $93.07 | -2.88% |
IE
|
|
| $297.13 | -21.76% |
US
|
|
| $44.47 | -55.49% |
US
|
|
| $46.69 | -17.17% |
DE
|
